DementiaGreat RiskMotor VehicleRoad SafetyIn patients with dementia, the prescription of neuropsychotherapeutic drugs should make doctors consider road safety, according to researchers from Canada and the US. They conducted a population-based case-crossover study for Ontario, Canada, during April 1, ...
From a cognitive standpoint, levetiracetam was the anticonvulsant most examined in patients with dementia, it appears to have less deleterious effects than some anticonvulsants. Limited data are available on the safety of these medications in elderly patients; however, studies completed thus far have ...
between bodily impairment and disability and associated disadvantage created by environmental and social exclusion [99]. Secondly,the distinction between medical and social models also resonates with previous qualitative research on patient safety highlighting the tendency of patients to highlight the importa...
Association between proton pump inhibitors and dementia risk: a Mendelian randomization study Kexin Xie ,Jing Li &Ming Chen Article 18 November 2024|Open Access Viral reactivation and clinical outcomes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) ...
Focuses on the effort of government in assuring safety for people with dementia in long-term care facilities in the U.S. Determination of the technical aspects of physical care and cleanliness; Characteristics of staff in dementia care facilities; Determination of the statewide initiative to gain un...
Teaching/learning packets were developed to “keep each patient safe”by calling for help early; from falls and confusion; and from hospital-acquired infections (http//McKeesport.upmc.com/KeepingPatientsSafe.htm). Teaching/Learning Packets In July 2002, the concept of calling for help early ...
This randomized clinical trial compares the effects of 3 dose levels of intranasal esketamine with placebo in patients with treatment-resistant depression.
Idebenone in the treatment of multi-infarct dementia: a randomised, double-blind, placebo controlled multicentre trial A controlled double blind randomised open multicentre study was carried out on 104 patients with multi-infarct dementia (MID) from a mild to a moderate deg... B Bergamasco,C Vil...
Memantine was well tolerated with a frequency of adverse events comparable to placebo. CONCLUSIONS: In patients with mild to moderate vascular dementia, memantine 20 mg/d improved cognition consistently across different cognitive scales, with at least no deterioration in global functioning and behavior....
Comparison of the Effi cacy and Safety of Memantal and the Original Drug Memantine in Mild and Moderate Alzheimer's Disease-Associated Dementia cacy and safety of the original drug memantine and the generic drug (memantal) in patients with mild and moderate dementia in Alzheimer's disease (AD)...